<DOC>
	<DOC>NCT00812201</DOC>
	<brief_summary>This study will collect data on a new feature for future heart failure devices via an external non-implantable system.</brief_summary>
	<brief_title>Evaluation of Left Ventricular AutoThreshold</brief_title>
	<detailed_description>ELEVATE is an acute, prospective, multi-center, feasibility study with a randomized within patient test sequence and pulse width, designed to characterize the performance of the Left Ventricular Auto Threshold feature.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients who are scheduled to receive a CRTP or CRTD, based on physician discretion Patients who are willing and capable of participating in all testing associated with this study Patients who are 18 or above, or of legal age to give informed consent specific to state and national law Patients who have, or are scheduled to receive a unipolar LV pace/sense lead to be used with the CRTP/CRTD device, unless the patient has any commercially available epicardial leads with at least two electrodes (from one or more leads) Patients with preexisting leads other than those specified in this investigational plan (unless the Investigator intends to replace them with permitted leads) Patients with a preexisting unipolar pacemaker that will not be explanted/abandoned Patients enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study Patients with a prosthetic mechanical tricuspid heart valve Women who are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>auto threshold</keyword>
	<keyword>pacing</keyword>
	<keyword>CRT-P or CRT-D recipients, threshold measurements</keyword>
</DOC>